Czerniejewska-Wolska Hanna, Kałos Magdalena, Sekula Alicja, Piszczatowski Bartosz, Rutkowska Justyna, Rogowski Marek, Zadrożniak Marek, Szymański Marcin, Klatka Janusz, Durko Marcin, Pietruszewska Wioletta, Gawłowska Maria Bratumiła, Kuśmierczyk Joanna, Kruk-Krzemień Anna, Wiskirska-Woźnica Bożena
Katedra i Klinika Foniatrii i Audiologii Uniwersytetu Medycznego w Poznaniu.
Klinika Otolaryngologii Uniwersytetu Medycznego w Białymstoku.
Otolaryngol Pol. 2015;69(4):34-9. doi: 10.5604/00306657.1163575.
Multicenter evaluation of the quality of life and quality of hearing after Nucleus® cochlear implant placement in patients over 60 years of age.
Evaluation was performed in patients receiving cochlear implants after the age of 60 years as a part of the Cochlear-Implanted Recipient Observational Study (Cochlear-IROS). This study is a prospective, international and long-term assessment which enables observation of recipients for up to three years after implantation. Data regarding subjective evaluation of the quality of life and quality of hearing were gathered before the first switch-on of the sound processor and one year afterwards. Standardized questionnaires were used in this evaluation, including Health Utility Index (HUI mk. III) and Speech, Spatial and Qualities of Hearing (SSQ) Scale. Data were also gathered regarding the aetiology of hearing loss, hearing aid usage, tinnitus and vertigo, as well as on the telephone usage and the professional status of recipients.
Included in the evaluation, were 20 subjects who were over 60 years old at the moment of the cochlear implant surgery. The study group consisted of 12 men and 8 female patients. The average age of CI recipients at the moment of implantation was 67.8 years (min. 60, max. 80 years). The SSQ questionnaire outcomes regarding self-assessment in the field of ability to hear in everyday situations one year after the surgery indicate that speech understanding increased by 180%, spatial hearing increased by 135 % and quality of hearing increased by 98%. Overall quality of life before the first sound processor switch-on as assessed using the HUI questionnaire was at the level of 0.38 (on 0-1 scale, where 0 equals death, and 1 equals full health). One year after the implantation, this assessment increased by 33% (up to 0.5 on the scale).
The effectiveness of the cochlear implantation in patients with severe hearing loss after 60 years of age with respect to the quality of life and hearing was confirmed. Statistically significant improvement was demonstrated in the self-assessment of patients in relation to the speech understanding, spatial hearing and quality of hearing, as well as quality of life.
对60岁以上患者植入Nucleus®人工耳蜗后的生活质量和听力质量进行多中心评估。
作为人工耳蜗植入受者观察性研究(Cochlear-IROS)的一部分,对60岁以后接受人工耳蜗植入的患者进行评估。本研究是一项前瞻性、国际性的长期评估,能够在植入后对受者进行长达三年的观察。在声音处理器首次开机前和开机一年后收集有关生活质量和听力质量主观评估的数据。本次评估使用标准化问卷,包括健康效用指数(HUI mk. III)和言语、空间与听力质量(SSQ)量表。还收集了有关听力损失病因、助听器使用情况、耳鸣和眩晕的数据,以及受者的电话使用情况和职业状况。
评估纳入了20名在人工耳蜗植入手术时年龄超过60岁的受试者。研究组由12名男性和8名女性患者组成。植入人工耳蜗时受者的平均年龄为67.8岁(最小60岁,最大80岁)。术后一年SSQ问卷关于日常听力能力自我评估的结果表明,言语理解能力提高了180%,空间听力提高了135%,听力质量提高了98%。使用HUI问卷评估,首次开机前的总体生活质量为0.38(0-1量表,0表示死亡,1表示完全健康)。植入一年后,该评估提高了33%(量表上达到0.5)。
证实了人工耳蜗植入对60岁以上重度听力损失患者的生活质量和听力的有效性。患者在言语理解、空间听力、听力质量以及生活质量的自我评估方面显示出统计学上的显著改善。